Home Ventilator Research:CAGR of 8.7% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Home Ventilator- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Home Ventilator market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Home Ventilator was estimated to be worth US$ 3736 million in 2024 and is forecast to a readjusted size of US$ 8020 million by 2031 with a CAGR of 11.7% during the forecast period 2025-2031.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/3430061/home-ventilator

Product Overview and Scope of Home Ventilator

A home ventilator is a non-invasive, slightly positive pressure ventilation device. It generates a continuous airflow through a main motor, which is humidified by a humidifier and then delivered into the patient's airway via tubing and a mask. It only assists with external respiration to complete alveolar ventilation, having minimal impact on internal respiration (gas exchange). It is suitable for individuals with sleep apnea (OSA), chronic obstructive pulmonary disease (COPD), and mild to moderate respiratory failure who can breathe independently.

The industry chain is characterized by "high concentration and heavy imports": Upstream core components-such as micro-turbine fans, precision sensors, PCBA boards, and liquid silicone masks-still rely on imports, accounting for over 50% of costs; Midstream manufacturing is dominated by overseas brands such as Philips and ResMed, which together account for 65% of the Chinese market share. Domestic leader Yihe Jiaye ranks third with approximately 15%, and the industry's gross profit margin is 30-50%, relying on rapid distribution through dealerships; Downstream access is through medical device specialty stores, e-commerce, and hospitals, reaching patients directly. The domestic OSA diagnosis rate is

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.